When the analysis was performed using a cohort of ER-positive and tamoxifen-treated patients with BC (n = 210) 42, a significant correlation was observed between the reduced overall survival and high SETD1A mRNA expression levels (P = 0.0086; Figure 1B). This evidence concerns the gene SETD1A and breast cancer.